The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health

Martini D, Galli C, Guareschi C, Angelino D, Bedogni G, Biasini B, Zavaroni I, Pruneti C, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Del Rio D

NFS Journal 10:10-25

2018

Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults

Martini D, Innocenti A, Cosentino C, Bedogni G, Zavaroni I, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Pruneti C, Del Rio D

Arch Ital Biol. 156(1-2):64-86. doi: 10.12871/00039829201817

2018

 

Methylsulfonylmethane and mobilee prevent negative effect of IL-1β in human chondrocyte cultures via NF-κB signaling pathway

Cheleschi S, Fioravanti A, De Palma A, Corallo C, Franci D, Volpi N, Bedogni G, Giannotti S, Giordano N

International Immunopharmacology 65:129-139

2018

 

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed, under European Community Regulation 1924/2006 in the area of appetite ratings and, weight management

Martini D, Biasini B, Rossi S, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna R, Del Rio D

Int J Food Sci Nutr. 69(4):389-409. doi: 10.1080/09637486.2017.1366433

2018

 

Neuro-inflammatory effects of photodegradative products of bilirubin

Jašprová J, Dal Ben M, Hurný D, Hwang S, Žížalová K, Kotek J, Wong RJ, Stevenson DK, Gazzin S, Tiribelli C, Vítek L

Sci Rep. 8(1):7444. doi: 10.1038/s41598-018-25684-2

2018

 

Resting energy expenditure in children with cerebral palsy: Accuracy of available prediction formulae and development of a population-specific formula

Penagini F, Borsani B, Bosetti A, Mameli C, Dilillo D, Ramponi G, Motta F, Bedogni G, Zuccotti GV

Clin Nutr ESPEN. 25:44-49. doi: 10.1016/j.clnesp.2018.04.006

2018

 

Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health

Martini D, Guareschi C, Biasini B, Bedogni G, Galli C, Angelino D, Marchi L, Zavaroni I, Pruneti C, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Del Rio D

PharmaNutrition 6:17-36

2018

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations

Martini D, Biasini B, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Del Rio D

Acta Diabetol. 55(4):391-404. doi: 10.1007/s00592-017-1095-6

2018

 

Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy

Moretti R, Caruso P, Tecchiolli M, Gazzin S, Tiribelli C

World J Hepatol. 10(3): 379-387

2018

 

Gut microbiota characterisation in obese patients before and after bariatric surgery

Campisciano G, Palmisano S, Cason C, Giuricin M, Silvestri M, Guerra M, Macor D, De Manzini N, Crocé LS, Comar M                                                                                                                             

Benef Microbes. Feb 27:1-8. doi: 10.3920/BM2017.0152.

2018

 

Alcohol, liver and genes: an intricate puzzle

Rosso N & Tiribelli C

Ann Hepatol. Nov-Dec; 12(6):860

2013

The biological implication of the cancer stem cells in hepatocellular carcinoma: a possible target for future therapy

Sukowati CHC & Tiribelli C

Expert Review of Gastroenterology & Hepatology. Nov;7(8):749-57

2013

Jay Donald Ostrow: the yellow giant

Tiribelli C, Vitek L, Wennberg R

Hepatology. Apr. 1679-1680

2013

The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?

Nobili V, Bedogni G, Berni Canani R, Brambilla P, Cianfarani S, Pietrobelli A, Agostoni C.

 Pediatr Obes. Dec;7(6):e75-80

2012

Transport and metabolism at blood-brain interface and in neural cells: relevance to bilirubin-induced encephalopathy

Gazzin S, Starzielle N, Tiribelli C, Ghersi-Egea JF.

Frontiers in Drug Metabolism and Transport.; May 18;3:89.

2012

Bilirubin-induced neurological damage

Gazzin S, Tiribelli C

J Matern Fetal Neonatal Med. Oct;24 Suppl 1:154-5

2011

ASH and NASH

Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S

Dig Dis. Jul; 29(2): 202-10

2011

In vitro models for the study of non-alcoholic fatty liver disease

Chavez-Tapia NC, Rosso N, Tiribelli C

Curr Med Chem. 18(7):1079-84

2011

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma disease (copia)

Sukowati CHC, Rosso N, Crocè LS, Tiribelli C.

World J Hepatol Mar, 2(3): 114-126

2010

Unbound (Free) Bilirubin (Bf): Improving the Paradigm for evaluating neonatal jaundice

Ahlfors CE, Wennberg RP, Ostrow JD, and Tiribelli C.

Clin Chem, July, 55:1288-1299. (rev) 

2009